Progesterone Capsule
Product Images NDC 59651-152

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 59651-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Progesterone Fig1)

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

This is a description for Progesterone Capsules, containing 100 mg microrized progesterone USP. It contains USPANF-defined storage instructions, possible dosage instructions and a seal requirement. It should not be used if allergic to peanuts, and should be dispensed as defined. It is distributed by Aurobinde Pharma USA, Inc., and is manufactured in India. There are also some additional markings and codes printed which are not part of the description.*

FDA Label Image

Package Label-principal Display Panel (200 mg (100 Capsules Bottle))

FDA Label Image

Chemical Structure (Progesterone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.